A detailed history of New Edge Advisors, LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, New Edge Advisors, LLC holds 16,949 shares of AMRN stock, worth $7,457. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,949
Previous 46,454 63.51%
Holding current value
$7,457
Previous $32,000 68.75%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.57 - $0.8 $16,817 - $23,604
-29,505 Reduced 63.51%
16,949 $10,000
Q2 2024

Aug 15, 2024

BUY
$0.63 - $1.07 $27,817 - $47,244
44,154 Added 1919.74%
46,454 $32,000
Q4 2023

Feb 13, 2024

SELL
$0.66 - $0.91 $1,650 - $2,275
-2,500 Reduced 52.08%
2,300 $2,000
Q3 2023

Nov 14, 2023

BUY
$0.85 - $1.43 $1,955 - $3,289
2,300 Added 92.0%
4,800 $4,000
Q4 2022

Feb 14, 2023

BUY
$1.07 - $1.34 $2,675 - $3,350
2,500 New
2,500 $3,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.